Shared genetic architecture of COVID-19 and Alzheimer's disease

N Matveeva, I Kiselev, N Baulina, E Semina… - Frontiers in Aging …, 2023 - frontiersin.org
… between COVID-19 and Alzheimer’s disease, … both COVID-19 and Alzheimer’s disease,
and highlighted a panel of SNPs that includes candidate genetic risk markers of the long COVID-…

Assessment of COVID-19 lockdown effect on early Alzheimer disease progression

C Peña-Bautista, L Álvarez-Sánchez… - Journal of …, 2023 - Springer
… The aim of this study is to evaluate the effect of COVID-19 … However, most of the studies
analyzing the effect of COVID-19-… condition associated to COVID-19 pandemic on cognitive …

[HTML][HTML] Beyond “psychotropic”: repurposing psychiatric drugs for COVID-19, Alzheimer's disease, and Cancer

EJ Lenze, AM Reiersen… - The Journal of …, 2023 - legacy.psychiatrist.com
… ’s use in COVID-19 and provide guidance on how to … COVID-19 and long COVID. We also
describe putative mechanisms of psychiatric drugs in treating long COVID, Alzheimer’s disease

Alzheimer's and Parkinson's diseases predict different COVID-19 outcomes: a UK Biobank study

Y Yu, M Travaglio, R Popovic, NS Leal, LM Martins - Geriatrics, 2021 - mdpi.com
… individuals tested for COVID-19 between March and … Alzheimer’s disease predicts the
highest risk of COVID-19 and mortality among elderly individuals. In contrast, Parkinson’s disease

Single-nucleus RNA sequencing reveals the shared mechanisms inducing cognitive impairment between COVID-19 and Alzheimer's disease

Y Fu, Z Guo, Y Wang, H Zhang, F Zhang, Z Xu… - Frontiers in …, 2022 - frontiersin.org
… To investigate cell diversity and disease-related cellular dysfunction with respect to similar
pathogenic mechanisms between AD and COVID-19, we included snRNA-seq and AD high-…

Preferences of NIA Alzheimer's Disease Research Center participants regarding remote assessment during the COVID19 pandemic

M Nunnerley, N Mattek, J Kaye… - Alzheimer's & Dementia …, 2022 - Wiley Online Library
… Prior to the COVID-19 pandemic these assessments were … a survey (the COVID-19 Technology
Accessibility Survey or CTAS [… these questions because COVID-19 has presented new …

The intersection between COVID-19, the gene family of ACE2 and Alzheimer's disease

MM Haghighi, EG Kakhki, C Sato… - Neuroscience …, 2020 - journals.sagepub.com
… susceptibility to COVID-19. Notably, dysregulation of the RAS-equilibrium contributes to
Alzheimer’s disease. Differences in the incidence and symptoms of COVID-19 in diverse …

Identifying New COVID-19 receptor neuropilin-1 in severe Alzheimer's disease patients group brain using genome-wide association study approach

KH Lim, S Yang, SH Kim, JY Joo - Frontiers in genetics, 2021 - frontiersin.org
coronavirus 2 (SARS-CoV-2). Thus, we hypothesize that NRP1 may be upregulated in
Alzheimer’s disease … Many cases of severe symptoms of COVID-19 are concentrated in an elderly …

A genome-wide cross-trait analysis highlights the shared genetic structure between COVID-19 and Alzheimer's disease

S Qiu, Y Hu, L Cheng - The Journal of Infection, 2022 - ncbi.nlm.nih.gov
… ) analysis to reveal the causality between Alzheimer's disease and COVID-19. When
Alzheimer's disease was used as exposure and COVID-19 as outcome, 18 genetic variants were …

[HTML][HTML] COVID-19 and Alzheimer's disease: Impact of lockdown and other restrictive measures during the COVID-19 pandemic

AD Nawaz, MZ Haider, S Akhtar - Biomolecules and Biomedicine, 2024 - ncbi.nlm.nih.gov
… with Alzheimer’s … COVID-19, dementia, Alzheimer’s disease, lockdown, and caregivers.
Our review highlights that patients with Alzheimer’s disease face an increased risk of COVID-19